Author

M. Krauthammer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Approach:experimental assay· 3 Research Focus:gene regulatory network inference· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

Z. Balazs· 2 shared A. Aloia· 1 shared A. Bileck· 1 shared A. Dzung· 1 shared A. E. Frick-Cheng· 1 shared A. Irmisch· 1 shared A. Kolz· 1 shared A. Leitner· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Z. Balazs

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Memory Th1 cells modulate heterologous diseases through innate function

N. Rakebrandt, N. Yassini, A. Kolz, M. Schorer, K. Lambert, C. Rauld, Z. Balazs, M. Krauthammer, J. Carballido, A. Peters, N. Joller

This study identifies memory Th1 cells that can respond rapidly to unrelated pathogens or diseases through TCR-independent IFN-γ production, influencing susceptibility to heterologous challenges.

bioRxiv · Mar 22, 2023 · PreprintImmunology

ROS induction as a strategy to target persister cancer cells with low metabolic activity in NRAS mutated melanoma

O. M. Eichhoff, C. I. Stoffel, J. Kaesler, L. Briker, P. Turko, G. Karsai, N. Zila, V. Paulitschke, P. F. Cheng, A. Leitner, A. Bileck, N. Zamboni, A. Irmisch, Z. Balazs, A. Tastanova, , M. Levesque

The paper identifies ROS induction as a strategy to target MEK-inhibitor resistant NRAS-mutated melanoma cells by exploiting their quiescent metabolic state and elevated baseline ROS levels.

bioRxiv · Oct 19, 2022 · PreprintCancer Biology

The Gene Expression Profile of Uropathogenic Escherichia coli in Women with Uncomplicated Urinary Tract Infections Is Recapitulated in the Mouse Model

A. E. Frick-Cheng, A. Sintsova, S. N. Smith, M. Krauthammer, K. A. Eaton, H. L. T. Mobley

This study compares gene expression of UPEC in human UTIs and a mouse model, finding strong correlation and validating the mouse model's utility for UTI research.

mBio · Aug 25, 2020Peer-reviewedMicrobiology

Chromatin-Bound PARP1 Correlates with Upregulation of Inflammatory Genes in Response to Long-Term Treatment with Veliparib

I. Alvarado-Cruz, M. Mahmoud, M. Khan, S. Zhao, S. Oeck, R. Meas, K. Clairmont, V. Quintana, Y. Zhu, A. Porciuncula, H. Wyatt, S. Ma, Y. Shyr, Y. Kong, P. M. LoRusso, , J. B. Sweasy

This study shows that long-term veliparib treatment leads to chromatin-bound PARP1 and upregulation of inflammatory genes in BRCA1 mutant cells, but not in BRCA1-complemented cells.

bioRxiv · Mar 8, 2020 · PreprintCancer Biology